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OBJECTIVES This study aimed to investigate prospectively the protective effect of a first preinfarction
angina attack against acute myocardial infarction (AMI) in human hearts without significant
collaterals.
BACKGROUND Several retrospective studies and the prospective studies have demonstrated the existence of
the preconditioning (PC) effect in humans. However, collaterals were not examined in the
prospective studies. In animal models, the PC effect on myocardial infarct size appears soon
after PC reperfusion (classic) but disappears within 1 to 2 h. It then reappears 24 to 48 h after
reperfusion (the delayed PC effect). Meanwhile, the PC effect on stunning appears 12 h after
PC reperfusion (the delayed PC effect). The concept of the classic and delayed PC effects has
not been investigated in human AMI studies. If the above concept is also correct in humans,
the infarct size and/or impairment of the left ventricular function should be inversely
correlated with the time interval between the first preinfarction angina attack and the onset
of AMI when that time interval is limited to between 2 and 48 h.
METHODS The subjects were 25 patients with first AMI of the proximal left anterior descending artery
who underwent successful direct percutaneous transluminal coronary angioplasty (PTCA) 2
to 6 h after the onset and with no (or poor) collateral circulation (grade 0 or 1). They were
divided into two groups: preinfarction angina (PA)(1) group: 11 patients with new onset
preinfarction angina from 2 to 48 h before the onset, PA(2) group: 14 patients without
angina before infarction. Peak creatine kinase (CK) and cumulative CK were examined, and
the left ventricular ejection fraction (LVEF) and the regional wall motion (RWM) were
determined from the left ventriculograms during the acute (immediately after the coronary
reperfusion) and chronic (four weeks after the onset of AMI) phases. The RWM index
(RWMI) was then calculated as the mean motion of chords (standard deviation [SD]/chord)
lying in the area of chords of RWM # 22 SD in the acute phase (ischemic risk area).
RESULTS The increase in the RWMI between the acute and chronic phases was significantly larger in
the PA(1) group than in the PA(2) group (1.55 6 1.32 and 0.69 6 0.75, p , 0.05,
respectively) although no significant difference in the enzymatic infarct size was seen between
the two groups. The increases in the LVEF and the RWMI were significantly correlated with
the time interval from the first preinfarction angina attack to the onset of AMI (r 5 0.622,
p , 0.05 and r 5 0.646, p , 0.05, respectively), but the enzymatic infarct size was not.
CONCLUSIONS The beneficial effect of preinfarction angina on left ventricular wall motion, independently of
collateral flows, indicates the existence of the PC effect in humans. The greater protective
effect of a longer time interval between angina pectoris and AMI suggests that the protection
is due to a delayed PC effect. (J Am Coll Cardiol 1999;34:1966–74) © 1999 by the American
College of Cardiology
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Recently, several retrospective studies (1–5) and the pro-
spective studies (6,7) demonstrated that angina attack be-
fore acute myocardial infarction (AMI) exerts a precondi-
tioning (PC) effect in humans. However, collaterals, which
play an important role on the infarct size, were not exam-
ined in the prospective studies (6,7). Therefore, it has not
been established whether preinfarction angina has a PC
effect.
In experimental animal models (8,9), transient myocar-
dial ischemia before sustained myocardial ischemia reduced
the infarct size to one-third to one-eighth of the ischemic
risk area, which did not depend on collateral circulation.
This classic PC effect is lost if the time interval of reperfu-
sion before sustained ischemia becomes more than 35 to
60 min in anesthetized rabbits (10,11), more than 2 to 4 h
in conscious rabbits (12), more than 2 h in anesthetized
dogs (13,14) or more than 60 min in anesthetized pigs (15).
However, 24 to 48 h after PC reperfusion, the myocardial
protective effects against sustained ischemia again appear
(the delayed PC effect or the second window of PC effect)
(14,16–18). However, this delayed PC effect on myocardial
infarct size is still controversial (19,20). Meanwhile, it has
been established in pigs (21,22) and rabbits (23) that the PC
effect against myocardial stunning appears 24 h after PC
reperfusion (the delayed PC effect).
The presence of a classic PC effect with a short time
interval in the human heart has been reported using the
percutaneous transluminal coronary angioplasty (PTCA)
model (24) and the cardiac surgery model (25,26), but even
these findings are still controversial (27,28). The concept of
the short-duration classic PC effect followed by its disap-
pearance, and then the reappearance of the delayed PC
effect with a relatively long duration, has not been examined
in any human studies. In other words, it is unknown
whether the delayed PC effects on myocardial infarct size
and stunning are present or not in human hearts. Our
hypothesis is that, if the delayed PC effect is present, the
enzymatic infarct size and/or the improvement of left
ventricular function should be inversely correlated with the
time interval between the first and/or last preinfarction
angina attack and the onset of AMI, when that time interval
is limited to between approximately 2 and 48 h. However,
various factors that affect the enzyme release and left
ventricular wall motion, such as the infarct-related artery,
the grade of collateral flow, the time interval from the onset
of AMI to reperfusion and the grade of recanalization, must
also be considered in this analysis.
Thus, to determine whether the preinfarction angina has
a PC effect independent of collateral flow, and whether the
delayed PC effect exists in humans, the preinfarction angina
attacks and their protective effect against AMI were exam-
ined prospectively in patients with first AMI. In whom, the
infarct-related artery was the proximal left anterior descend-
ing artery; the grade of collateral flow at the time of AMI
before the recanalization was Rentrop grade 0 or 1 (29); the
culprit lesion was successfully recanalized by direct PTCA
between 2 and 6 h after the onset of AMI, and there was no
evidence of restenosis on coronary angiography performed
one month after the onset of AMI.
METHODS
Study subjects. From August 1, 1995, until June 31, 1997,
26 institutions in Japan participated in this study. Patients
with AMI who met the inclusion criteria were enrolled in
this study within two days after the onset of infarction. The
presence of preinfarction angina was diagnosed by the
patients’ doctors from the detailed clinical history within
24 h after the onset of infarction and was reconfirmed by an
experienced doctor within two weeks. Angina was defined
when the patients had symptoms (such as chest pain, chest
discomfort, left arm pain or jaw pain) for no longer than
30 min which were considered to be of cardiac origin.
The inclusion criteria were: 1) patients with AMI who
exhibited new-onset, typical angina within two days before
the onset of AMI or who never exhibited angina before the
onset of AMI, 2) a first AMI with typical chest pain lasting
longer than 30 min, 3) the culprit lesion was in the proximal
left anterior descending artery, which was totally occluded
Thrombolysis in Myocardial Infarction flow grade 0 (TIMI
0) (30), with no other significant stenosis ($75%) of the
other vessels, 4) collateral circulation was Rentrop grade 0 or
1 (29) on coronary angiography during the acute phase
(because when the collateral circulation was greater [30], the
myocardium of the infarct area was better salvaged), 5) more
than two leads with more than 2 mm ST elevation in the
anterior precordial leads of the electrocardiogram, 6) a
greater than threefold increase in serum creatine kinase
(CK) level, 7) patients with shock were excluded, 8) the
culprit lesion was successfully reperfused by direct PTCA
between 2 and 6 h after the onset of AMI (because when the
time interval from the onset of AMI to reperfusion was
within 2 h, the myocardium of the infarct area was definitely
better salvaged [31] and also because it is very difficult to
recanalize the culprit lesion by direct PTCA within 2 h from
the onset of AMI) and became less than 50% stenosis
without the no-reflow phenomenon (32), and 9) no treat-
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ment with glibenclamide for diabetes (because it might have
affected the results of this study [33]).
During the follow-up period, patients were dropped from
the analysis when there was: 1) more than 75% stenosis of
the infarct-related artery during the chronic phase (four
weeks after the onset of AMI), 2) ischemic events during
the follow-up period, or 3) other events which would affect
the left ventricular wall motion, including left ventricular
rupture or pericardial effusion.
Study protocol. At the time of admission, all patients
underwent coronary angiography, coronary reperfusion
therapy and left ventriculography immediately after the
coronary reperfusion. Then, during the chronic phase (four
weeks after the onset), they again underwent coronary
angiography and left ventriculography to evaluate the pres-
ence of restenosis and the left ventricular wall motion.
Written informed consent for cardiac catheterization and
coronary angioplasty was obtained from each patient.
Patients’ characteristics. Information about the patients’
age, gender, the presence of preinfarction angina, the time
interval from the onset of AMI to coronary reperfusion and
the clinical events during reperfusion therapy was collected.
When preinfarction angina existed, the frequency, time,
duration and strength of attacks and whether they occurred
during effort or at rest were determined. The coronary risk
factors (smoking, hyperlipidemia, diabetes and hyperten-
sion), the treatment and the prognosis were examined.
Enzymes. The plasma level of CK was measured on
admission every 3 h for the first 18 h and every 12 h from
24 to 72 h after admission. The values at each institution
were normalized by dividing the value by the upper limit of
normal at each institution. The peak value of the plasma CK
(units) and the cumulative plasma CK integrated over the
first 72 h (multiples of upper limit of normal-hours) were
calculated from a 72-h time-activity curve of plasma CK
(34).
Analysis of the data of cardiac catheterization. Cine-
films, including coronary arteriograms and left ventriculo-
grams, were separately analyzed by two physicians who were
blinded to the clinical information. If there were differences,
they were resolved by consensus between the two observers.
Coronary angiography. Coronary artery segments were
identified according to the reporting system of the Ameri-
can Heart Association, and it was determined whether the
culprit lesion was proximal or distal to the first major septal
branch and whether it was proximal or distal to the first
major diagonal branch. On the coronary arteriograms at the
onset of AMI, the development of the angiographic collat-
eral circulation was graded: 0 5 none; 1 5 filling of side
branches of the artery to be dilated via collateral channels
without visualization of the epicardial segment, 2 5 partial
filling of the epicardial segment via collateral channels, 3 5
complete filling of the epicardial segment of the artery being
dilated via collateral channels (29). In this study, only
patients with grade 0 or 1 were enrolled.
Left ventriculography. The left ventriculograms were ob-
tained in the 30° right oblique views immediately after
reperfusion and during the chronic phase. The left ventricu-
logram was analyzed with a Kontron Cardio 500 system
(Konton Electronik, Munich). The left ventricular endocar-
dial borders were hand-traced, and volumes were calculated
by the area-length method. End-diastolic and end-systolic
images were defined as when the left ventricular volumes
were maximal and minimal, respectively. The left ventricu-
lar ejection fraction (LVEF) (%) was calculated as: (left
ventricular end-diastolic volume [LVEDV] 2 end-systolic
volume) 3 100/LVEDV.
Regional wall motion (RWM) was assessed from the left
ventriculogram using the centerline method along 100
chords drawn perpendicular to a centerline constructed
midway between the end-diastolic and end-systolic con-
tours. The measured motion of the 100 chords was normal-
ized for heart size by dividing by the length of the
end-diastolic perimeter. This normalized chord motion was
expressed in units of standard deviations (SD) from the
mean wall motion of normal subjects (35). The regional wall
motion index (RWMI) was calculated as the mean motion
of chords (SD/chord) lying in the area of chords of RWM
#22 SD at acute phase (ischemic risk area).
Statistical analyses. All data are presented as mean 6 SD.
The paired Student t test was used to compare the two
sequential values obtained during the acute and chronic
phases. A two-way repeated-measures analysis of variance
and Scheffe´’s F test were used to determine the effects of
phases and preinfarction angina on the angiographic param-
eters. One-way analysis of variance and Scheffe´’s F test were
used to compare continuous data between two groups.
Chi-square analysis was used to compare categorical data. A
value of p , 0.05 was considered statistically significant.
RESULTS
Clinical data. Thirty-seven patients were enrolled at the
onset of AMI. Eighteen patients exhibited preinfarction
angina (PA) (new-onset) within 48 h before the onset of
AMI (PA[1] group) and 19 patients were free from PA
(PA[2] group). In the PA(1) group, one patient had left
ventricular rupture on the fourth day after infarction and
had to be operated on urgently and one had pericardial
effusion on the second day of infarction; two patients were
found, after precise history-taking by an experienced doctor,
to have angina attacks more than 48 h (79 h and two
months) before the onset of AMI. In the PA(2) group, one
patient suddenly died four days after the onset of AMI due
to reinfarction, and the left ventriculogram of one patient
during the acute phase was not suitable for analysis. During
the chronic phase in the PA(1) group, one patient suffered
an angina attack on the thirteenth day after infarction and
had restenosis at the culprit lesion; one patient had resten-
osis at the culprit lesion and one had worsened chronic renal
failure so that left ventriculography could not be performed.
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In the PA(2) group, one patient had restenosis on the
culprit lesion and, in two patients, the cardiac catheteriza-
tion could not be done four weeks after the onset of AMI.
Therefore, 12 patients were excluded from the analysis and
11 patients in the PA(1) group and 14 in the PA(2) group
were analyzed (Table 1).
There was no significant difference between the two
groups in age, gender, the time interval from the onset of
AMI to coronary reperfusion, the location of the culprit
lesion, the collateral circulation during the acute phase, the
clinical events during reperfusion therapy or the hemody-
namics during the acute phase of AMI. After reperfusion
therapy, patients were treated with antiplatelet agents (as-
pirin: 10 in the PA[1] group and 9 in the PA[2] group or
ticlopidine hydrochloride: 4 in the PA[1] group and 3 in
the PA[2] group) or potassium warfarin (2 in the PA[1]
group and 2 in the PA[2] group), and there were no
significant differences between any two groups.
Preinfarction angina. The characteristics of the PA are
summarized in Table 2. The first PA attack occurred 2 to
48 h (21.5 6 14.6 h) before the onset of AMI, and the last
one occurred 1.5 to 24 h (10 6 7.1 h) before the onset. The
frequency of the PA was one occurrence in four patients,
two occurrences in four, three occurrences in two and five
occurrences in one (2 6 1 occurrences). The duration of the
PA was 1 to 20 min, with an average of 7.0 min for the first
PA, 9 min for last one and 7 min for all episodes.
Enzymatic infarct size. The peak values of the plasma CK
levels were 22.1 6 9.2 units in the PA(1) group and 40.0 6
33.3 units in the PA(2) group. The cumulative plasma CK
values during the first 72 h were 601 6 198 units in the
PA(1) group and 774 6 459 units in the PA(2) group.
There was no significant difference in the peak values of the
plasma CK (p 5 0.10) or the cumulative plasma CK values
(p 5 0.26) between the PA(1) and PA(2) groups.
Angiographic left ventricular function (Table 3, Fig. 1).
The LVEF values in the PA(1) group and the PA(2)
group, were, during the acute phase, 45.7 6 9.7 and 51.4 6
8.9%, respectively, and during the chronic phase, 56.2 6
10.1 and 52.2 6 10.2%, respectively. The LVEF was
significantly increased in the PA(1) group (p , 0.05) but
not in the PA(2) group from the acute to chronic phases.
Two-way repeated-measures analysis of variance did not
show significant differences in the LVEF between the
PA(1) and the PA(2) groups (p 5 0.33). Therefore, the
LVEF during each phase or the change in the LVEF from
Table 1. Patient Characteristics
PA(1)
Group
PA(2)
Group
No. of patients 11 14
Age (yrs) 60 6 13 61 6 11
Gender (M/F) 8/3 10/4
Risk factors (%)
Diabetes 0 21
Hyperlipidemia 18 14
Hypertension 27 50
Smoking 55 57
Time interval from the onset
of AMI to reperfusion (min)
215 6 64 233 6 66
Collateral grade 0.5 6 0.5 0.3 6 0.5
Culprit lesion (proxymal/distal)
First major septal perforator 7/4 4/10
First diagonal branch 6/5 4/10
Peak CK (units) 22.1 6 9.2 40.0 6 33.3
Cumulative CK (units-integrated
over 1st 72 h)
601 6 198 774 6 459
Hemodynamics at acute phase
Mean blood pressure (mm Hg) 97 6 15 89 6 13
Heart rate (/min) 81 6 20 83 6 17
PAWP (mm Hg) 16 6 6 14 6 6
Cardiac index (L/min/m2 BSA) 3.0 6 0.5 2.9 6 0.9
ECG
No. of leads of ST elevation 4 6 1 4 6 1
AMI 5 acute myocardial infarction; BSA 5 body surface area; CK 5 creatine kinase;
ECG 5 electrocardiogram; PA 5 preinfarction angina; PAWP 5 pulmonary artery
wedge pressure.
Table 2. Characteristics of the PA
Range Mean 6 SD
Number of times of PA attack
before AMI
1–5 2.1 6 1.2
Time interval from the first PA
attack to the onset of AMI (h)
2–48 21.5 6 14.6
Time interval from the last PA
attack to the onset of AMI (h)
1.5–24 10.0 6 7.1
Duration of first PA attack (min) 1.0–30 7.0 6 8.2
Duration of last PA attack (min) 1.0–20 9.0 6 6.4
AMI 5 acute myocardial infarction; PA 5 preinfarction angina.
Table 3. Left Ventriculographic Parameters
PA(1) Group PA(2) Group
No. of patients 11 14
Left ventricular ejection
fraction (%)
Acute phase 45.7 6 9.7 51.4 6 8.9
Chronic phase 56.2 6 10.1† 52.2 6 10.2
Difference 10.5 6 12.5 0.8 6 10.1
Heart rate (/min)
Acute phase 83 6 15 79 6 20
Chronic phase 73 6 18 72 6 9
Regional wall motion
index (SD/chord)
Acute phase 23.36 6 0.57 23.33 6 0.58
Chronic phase 21.81 6 1.25*‡ 22.63 6 0.43‡
Difference 1.55 6 1.32* 0.69 6 0.75
PA 5 preinfarction angina.
*p , 0.05, compared with PA(2) group; †p , 0.05; ‡p , 0.01 compared with
acute phase.
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the acute to chronic phases was not compared between the
two groups.
The number of chords of RWM # 22 SD at the acute
phase (ischemic risk area) did not differ between the PA(1)
and the PA(2) groups (42.8 6 13.8 and 42.3 6 10.2,
respectively, p 5 NS). The RWMI in the PA(1) group and
the PA(2) group were, during the acute phase, 23.36 6
0.57 and 23.33 6 0.58 SD/chord, respectively, and, during
the chronic phase, 21.81 6 1.25 and 22.63 6 0.43
SD/chord, respectively. The RWMI was significantly in-
creased in both the PA(1) and the PA(2) groups (p , 0.01
and p , 0.01, respectively) from the acute phase to the
chronic phase. Two-way repeated-measures analysis of vari-
ance showed a significant difference in the RWMI between
the PA(1) and the PA(2) groups (p , 0.05). The RWMI
during the acute phase did not differ between the two
groups, but the RWMI during the chronic phase was
significantly larger in the PA(1) group than in the PA(2)
group (21.81 6 1.25 and 22.63 6 0.43, respectively, p ,
0.05). The increase in the RWMI was larger in the PA(1)
group than in the PA(2) group (1.55 6 1.32 and 0.69 6
0.75 SD/chord, respectively, p , 0.05).
Relation between enzymatic infarct size or left ventricu-
lar function and the time interval from preinfarction
angina to the onset of AMI (Figs. 2 and 3). The enzy-
matic infarct size was not correlated with the time interval
from either the first or the last PA to the onset of AMI.
Neither the LVEF nor RWMI during the chronic phase
was correlated with the time interval from the first or last
PA to the onset of AMI. However, the increases in both
LVEF and RWMI from the acute to chronic phases were
correlated with the time interval from the first PA to the
onset of AMI (r 5 0.622, p , 0.05 and r 5 0.646, p , 0.05,
respectively). The increase in the LVEF was correlated with
the time interval from the last PA to the onset of AMI (r 5
0.654, p , 0.05), but the increase in the RWMI was not.
There was no correlation between the above time intervals
and clinical variables such as age, gender, time interval from
the onset of AMI to reperfusion or collateral grade.
DISCUSSION
This prospective study demonstrated that the increase in the
RWMI between the acute and chronic phases of AMI was
significantly larger in patients with PA than in those
Figure 1. Comparison of the increase in the RWMI between the
PA(1) group and the PA(2) group. The increase in the RWMI
was significantly larger in patients with PA (PA[1] group) than in
patients without PA (PA[2] group). PA 5 preinfarction angina;
RWMI 5 regional wall motion index.
Figure 2. Relationship between the increase in the LVEF and the interval from the first or last PA attack to the onset of acute myocardial
infarction. The increase in the LVEF in patients with PA was positively correlated with the interval from the first PA attack to the onset
of acute myocardial infarction. LVEF 5 left ventricular ejection fraction; PA 5 preinfarction angina.
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without, irrespective of collateral flow, and that the time
interval from the first PA to the onset of AMI was positively
correlated with the increases in both LVEF and RWMI.
PA and enzymatic infarct size or left ventricular func-
tion. In this study, the increase in angiographic RWMI
from the acute phase to the chronic phase was significantly
larger in patients with PA than in patients without PA.
These data are consistent with those from previous retro-
spective studies (1,2). However, the enzymatic infarct size
did not differ between the patients with and without PA,
which is not consistent with the results of previous retro-
spective and prospective studies (1,7). This discrepancy may
be explained by the following facts. First, in two previous
retrospective and prospective studies (1,7), the collateral
flow at the onset of AMI, which has an effect on infarct size
(30), was not evaluated. However, in this study, it was
evaluated using the angiographic collateral grade (29),
which was well correlated with the collateral flow velocity
pattern assessed by a Doppler guide wire (36), and only the
patients with no or poor collateral flow were selected.
Second, the enzymatic infarct size is generally correlated
with the pathological infarct size, but it is influenced by the
time interval from the onset of AMI to reperfusion and the
area perfused by the culprit artery (37). Furthermore,
measurement of CK every 3 h would not be frequent
enough to detect the peak of CK. Therefore, the angio-
graphic infarct size, estimated from the improvement of left
ventricular RWM, might be more sensitive for detecting
small differences of infarct size than the enzymatic infarct
size, estimated from the cumulative plasma CK values.
Third, in previous retrospective studies (1,4) that showed a
significant difference of enzymatic infarct size, the time
from the onset of AMI to reperfusion was shorter than it
was in this study. Nagao et al. (4) demonstrated, using the
enzymatic infarct size, that the PC effect of PA was present
only when the time interval from the onset of AMI to
reperfusion was less than 1 h. Thus, if the time interval from
the onset of AMI to reperfusion is shorter, the difference of
infarct size may become larger and the enzymatic infarct size
may also become different between the PA(2) and the
PA(1) groups. However, this hypothesis remains unproved,
because it has not been investigated in a prospective study in
which collateral flow was considered. Fourth, beneficial
effects on myocardial stunning have been shown to be
related to the delayed PC effect, but not the classic PC
effect, in rabbit and pig models (21,22,38–40). Those
studies were performed using animal models without infarc-
tion (41). In addition, it is unclear whether left ventricular
dysfunction due to stunning can continue approximately
four weeks after prolonged ischemia, as seen in this study.
However, a recent study revealed that postinfarction con-
tractile dysfunction after reperfusion continues in the sal-
vaged myocardium one month or more after AMI (maimed
myocardium) (42) and then may cause incomplete recovery.
Another problem with stunning is that a preceding angina
attack may make the degree of stunning at the acute phase
after infarction larger, and this may explain the better
recovery in the PA(1) group at the one month follow-up.
However, the similar levels of RWMI at the acute phase in
the PA(1) and PA(2) groups disprove this possibility.
Thus, the protective effect on left ventricular wall motion
detected four weeks after AMI in this study may represent
differences in the extent of infarction (even if the crude CK
method did not reveal differences) and/or a protective effect
against maimed myocardium.
Figure 3. Relationship between the increase in the RWMI and the interval from the first or last PA attack to the onset of AMI. The
increase in the RWMI in patients with PA was positively correlated with the interval from the first PA attack to the onset of AMI. AMI 5
acute myocardial infarction; PA 5 preinfarction angina; RWMI 5 regional wall motion index.
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Delayed PC effect. The classic PC effect lasts from 35 to
120 min in the anesthetized animal models (10,11) and
from 2 to 4 h in conscious rabbits (12). This suggests that
the classic PC effect may disappear within several hours in
human hearts although we have no data in humans. Mean-
while, the delayed PC effect on infarct size is seen 24 h after
the PC stimulus in dogs (14) and from 24 to 72 h after the
PC stimulus in rabbits (16,43), although the precise time of
reappearance is unclear. The mechanism of the delayed PC
effect is still unclear, but the expression of heat shock
protein (16,19) or MnSOD (44,45) in myocardial tissues is
thought to be involved in the mechanism. In human hearts,
the classic PC effect using PTCA (24) and cardiac surgery
models (25), and the PC effect using the PA (1,2,4,7) have
been reported. Among those studies, only one (7) investi-
gated whether the delayed PC effect on infarct size was
present or not although the collaterals were not examined in
that study. In this study, the first PA attack occurred 2 to
48 h before the onset of AMI, and the last PA attack
occurred 1.5 to 24 h before the onset of AMI. Although
there was no significant difference in the enzymatic infarct
size, the improvement of the LVEF and RWMI in patients
with PA became larger when the time interval from the first
PA to the onset of AMI became longer, up to 48 h. This
strongly suggests the presence of the delayed PC effect in
human hearts. An alternative explanation for the positive
correlation between the left ventricular function and the
time interval is that a deleterious effect may appear when the
interval between angina and infarction is short compared
with when it is long. However, in this study, the RWMI
and LVEF at the acute and chronic phases and the changes
between acute and chronic phases in patients of the PA(1)
group, whose PA occurred a short time before AMI, were
similar to those of the PA(2) group. This fact does not
support the above scenario.
Study limitations. First, in this study as well as in previous
studies (1–7), the preinfarction ischemia for PC was diag-
nosed by the typical symptoms of angina before the onset of
AMI. Therefore, any patients with silent myocardial isch-
emia before the onset of AMI were put into the PA(2)
group in this study, and the number of any such patients is
unknown.
Second, in all patients of this study, the culprit lesion was
reperfused by direct PTCA, in contrast with the previous
studies (1–7). This procedure would make it difficult to
collect the patients of AMI recanalized within 2 h because
it is very difficult to recanalize the culprit lesion by direct
PTCA within 2 h from the onset of AMI. Therefore, we
excluded these patients. However, using this procedure, the
time of reperfusion was accurate and we could confirm that
the culprit lesion became less than 50% stenosis without the
no-reflow phenomenon.
Third, in human hearts, the classic PC effect has been
reported in the PTCA model (24) and surgical model
(25,26). However, we could not analyze the patients with
the first PA within 2 h. Therefore, the classic PC effect on
human infarct size remains unknown.
Fourth, in rabbits (11,46), preinfarction ischemia for 3 to
10 min produced the PC effects on infarct size, but ischemia
of less than 2 min did not. Conversely, preinfarction
ischemia for more than 15 min expanded the infarct size
(46). It was also reported that the PC effect of a very brief
period of ischemia was enhanced by repetition (11). How-
ever, Li et al. (9) reported that preconditioning with one
brief period of ischemia was as effective as PC with 10 cycles
of brief periods of ischemia. In this study, the effects of the
duration and number of PA attacks could not be analyzed
because of the small number of cases, and further investi-
gation is needed to determine these effects.
Finally, the number of patients in this study is somewhat
small compared with the numbers generally enrolled in
multicenter studies. However, each patient was strictly
selected as follows for this study: first AMI with single
vessel disease, culprit lesion of the proximal left anterior
descending artery which was totally occluded, no or poor
collaterals, successfully reperfused by direct PTCA between
2 and 6 h after the onset of AMI and without restenosis or
ischemic events during the follow-up period. Therefore, we
believe that the data are reliable.
In conclusion, 1) PA did not significantly reduce the
enzymatic infarct size, but can improve the increase in left
ventricular wall motion, 2) the beneficial effects of PA on
left ventricular wall motion are correlated positively with the
time interval from the first PA attack to the onset of AMI
when the time interval is limited from 2 to 48 h. These
effects do not depend on collateral circulation. This suggests
the presence of the delayed PC effect in human hearts.
APPENDIX
Clinical Centers (in Alphabetical order): Asahikawa City
Hospital, Tachida K, MD; Gifu Municipal Hospital,
Tanaka T, MD; Gifu University School of Medicine,
Fujiwara H, MD; Hiroshima City Hospital, Sato H, MD;
Iwate Medical University School of Medicine, Hiramori K,
MD; Kansai Rosai Hospital, Nanto S, MD; Kushiro City
General Hospital, Okada T, MD; Kyoto University,
Tanaka M, MD; Matsunami General Hospital, Morita N,
MD; Nagoya University School of Medicine, Ito T, MD;
National Cardiovascular Center, Nonogi H, MD; National
Toyohashi-Higashi Hospital, Suzuki T, MD; Nippon
Medical School Hospital, Takano T, MD; Osaka City
General Hospital, Haze K, MD; Osaka National Hospital,
Hayashi T, MD; Osaka University School of Medicine,
Hori M, MD, Tada M, MD; Prefectural Gifu Hospital,
Watanabe S, MD; Rakuwakai Otowa Hospital, Kida M,
MD; Sakurabashi Watanabe Hospital, Fujii K, MD; Sap-
poro Medical University School of Medicine, Miura T,
MD; Shinnittetsu Muroran General Hospital, Matsuki T,
MD; Social Welfare Juridical Person Hakodate Kouseiin
Hakodate Goryoukaku Hospital, Oimatsu H, MD; Suru-
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gadai Nihon University Hospital, Kanmatsuse K, MD;
Tokuyama Central Hospital, Ogawa H, MD; Tokyo
Women’s Medical College, Hosoda S, MD; Yamaguchi
University School of Medicine, Matsuzaki M, MD.
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